BMRN vs INDP · P/E 40, rev $1.76B vs $7.4M cap
Biomarin Pharmaceutical Inc (BMRN) versus Indaptus Therapeutics Inc (INDP) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Indaptus Therapeutics Inc (INDP) is a biotechnology company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
INDP does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. INDP currently screens at market cap $7.4M.
Not investment advice. Open the BMRN and INDP stock pages for the full models.
Not investment advice.